ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/06/30 | 2,690.5 | 2,696 | 2,645.5 | 2,662.5 | -33.5 | -1.2% | 235,500 |
2023/06/29 | 2,700 | 2,723 | 2,689 | 2,696 | -7.5 | -0.3% | 213,600 |
2023/06/28 | 2,653 | 2,704 | 2,653 | 2,703.5 | +50.5 | +1.9% | 191,000 |
2023/06/27 | 2,680 | 2,680 | 2,646 | 2,653 | -34 | -1.3% | 129,900 |
2023/06/26 | 2,690 | 2,703.5 | 2,661 | 2,687 | -1.5 | -0.1% | 135,400 |
2023/06/23 | 2,707 | 2,718 | 2,685 | 2,688.5 | -24 | -0.9% | 151,600 |
2023/06/22 | 2,719.5 | 2,723 | 2,707 | 2,712.5 | +4 | +0.1% | 127,500 |
2023/06/21 | 2,731.5 | 2,731.5 | 2,695 | 2,708.5 | -3 | -0.1% | 286,300 |
2023/06/20 | 2,730 | 2,730 | 2,700.5 | 2,711.5 | -21.5 | -0.8% | 164,500 |
2023/06/19 | 2,735 | 2,744 | 2,714 | 2,733 | -5 | -0.2% | 132,700 |
2023/06/16 | 2,718.5 | 2,745.5 | 2,706.5 | 2,738 | +11.5 | +0.4% | 279,800 |
2023/06/15 | 2,715 | 2,747.5 | 2,701.5 | 2,726.5 | -3.5 | -0.1% | 210,100 |
2023/06/14 | 2,820 | 2,821 | 2,683.5 | 2,730 | -90 | -3.2% | 481,800 |
2023/06/13 | 2,824 | 2,844 | 2,820 | 2,820 | -14 | -0.5% | 217,200 |
2023/06/12 | 2,854 | 2,860 | 2,823 | 2,834 | -2 | -0.1% | 146,500 |
2023/06/09 | 2,828.5 | 2,842 | 2,820 | 2,836 | +36.5 | +1.3% | 224,500 |
2023/06/08 | 2,838 | 2,839 | 2,788.5 | 2,799.5 | -43.5 | -1.5% | 291,300 |
2023/06/07 | 2,851 | 2,862 | 2,820 | 2,843 | -8.5 | -0.3% | 188,500 |
2023/06/06 | 2,818 | 2,854.5 | 2,795 | 2,851.5 | +35.5 | +1.3% | 238,000 |
2023/06/05 | 2,846 | 2,846 | 2,793.5 | 2,816 | +20 | +0.7% | 215,700 |
2023/06/02 | 2,747 | 2,799 | 2,743 | 2,796 | +31 | +1.1% | 161,100 |
2023/06/01 | 2,771 | 2,787 | 2,761 | 2,765 | +4 | +0.1% | 121,600 |
2023/05/31 | 2,788 | 2,809 | 2,761 | 2,761 | -52 | -1.8% | 361,600 |
2023/05/30 | 2,841 | 2,859 | 2,803 | 2,813 | -40 | -1.4% | 116,400 |
2023/05/29 | 2,851 | 2,862 | 2,837 | 2,853 | +21 | +0.7% | 197,300 |
2023/05/26 | 2,851 | 2,852 | 2,822 | 2,832 | -31 | -1.1% | 180,600 |
2023/05/25 | 2,861 | 2,885 | 2,854 | 2,863 | -3 | -0.1% | 226,800 |
2023/05/24 | 2,867 | 2,884 | 2,859 | 2,866 | ±0 | ±0% | 201,800 |
2023/05/23 | 2,870 | 2,884 | 2,849 | 2,866 | +46 | +1.6% | 291,800 |
2023/05/22 | 2,794 | 2,827 | 2,780 | 2,820 | +39 | +1.4% | 237,200 |
2023/05/19 | 2,788 | 2,794 | 2,767 | 2,781 | -17 | -0.6% | 137,100 |
2023/05/18 | 2,818 | 2,833 | 2,797 | 2,798 | -13 | -0.5% | 217,500 |
2023/05/17 | 2,792 | 2,817 | 2,783 | 2,811 | +21 | +0.8% | 268,000 |
2023/05/16 | 2,766 | 2,790 | 2,755 | 2,790 | +40 | +1.5% | 165,100 |
2023/05/15 | 2,736 | 2,752 | 2,717 | 2,750 | +33 | +1.2% | 185,600 |
2023/05/12 | 2,680 | 2,717 | 2,672 | 2,717 | +26 | +1% | 201,900 |
2023/05/11 | 2,709 | 2,711 | 2,677 | 2,691 | +1 | ±0% | 224,300 |
2023/05/10 | 2,652 | 2,699 | 2,649 | 2,690 | -112 | -4% | 457,900 |
2023/05/09 | 2,774 | 2,805 | 2,773 | 2,802 | +33 | +1.2% | 169,900 |
2023/05/08 | 2,752 | 2,775 | 2,751 | 2,769 | +17 | +0.6% | 127,600 |
2023/05/02 | 2,785 | 2,786 | 2,741 | 2,752 | -17 | -0.6% | 108,400 |
2023/05/01 | 2,777 | 2,785 | 2,759 | 2,769 | +17 | +0.6% | 137,400 |
2023/04/28 | 2,747 | 2,767 | 2,745 | 2,752 | +38 | +1.4% | 216,300 |
2023/04/27 | 2,713 | 2,716 | 2,693 | 2,714 | -6 | -0.2% | 128,800 |
2023/04/26 | 2,734 | 2,742 | 2,711 | 2,720 | -27 | -1% | 94,700 |
2023/04/25 | 2,739 | 2,765 | 2,737 | 2,747 | +12 | +0.4% | 132,000 |
2023/04/24 | 2,765 | 2,769 | 2,730 | 2,735 | -11 | -0.4% | 133,500 |
2023/04/21 | 2,719 | 2,756 | 2,714 | 2,746 | +27 | +1% | 237,200 |
2023/04/20 | 2,676 | 2,727 | 2,676 | 2,719 | +47 | +1.8% | 265,100 |
2023/04/19 | 2,664 | 2,676 | 2,658 | 2,672 | -5 | -0.2% | 182,600 |
451~
500
件表示中 / 3693件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 432,700円 | +20.9% | +87.3% | 3.14% | 9.67倍 | 1.12倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 437,300円 | +5.8% | +1.2% | 2.74% | 14.51倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 89,900円 | +26.8% | - | 0.00% | 15.13倍 | 3.12倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ペプチド | 190,600円 | +5.0% | +1.5% | 0.00% | 16.36倍 | 4.35倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 348,400円 | +7.9% | +8.9% | 3.56% | 7.45倍 | 1.00倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム